Actively Recruiting

Age: 1Month - 16Years
All Genders
NCT06899581

Gut Health in Children With Cancer

Led by Great Ormond Street Hospital for Children NHS Foundation Trust · Updated on 2025-03-28

40

Participants Needed

1

Research Sites

91 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to observe the impact leukaemia treatment has on gut health (microbiomes) and how quickly the gut health recovers after leukamia treatment. The gut microbiome has a number of important functions not only in the gut but within the whole body. Changes to your child's nutritional status throughout treatment may affect how well they recover from treatment. This study will monitor the impact of feeding and nutrition on nutritional status and gut health in young people undergoing treatment for leukaemia. The measurements needed to observe nutritional and gut microbiomes will occur when your child attends their routine medical appointments at Great Ormond Street Hospital. Medical treatment uses chemicals to kill leukaemia cells. The type of medications used in the treatment of leukaemia can damage the gut resulting in inflammation call mucositis. This stops the gut from working and sometimes nutrition has to be provided via a feeding tube or intravenous. Chemotherapy, mucositis and intravenous nutrition all have an impact on the gut. Little is know how the gut health recovers after treatment for leukaemia. This will be the first study to specifically monitor the impact of feeding and nutritional on gut health in children undergoing treatment for leukaemia. By understanding what changes are occurring to your child's nutritional status and gut halth during treatment and during recovery will help to develop guidelines for healthcare professionals to support optimal gut health recovery.

CONDITIONS

Official Title

Gut Health in Children With Cancer

Who Can Participate

Age: 1Month - 16Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Consented to partake in the study
  • Aged 0 to 16 years old
  • Diagnosed with AML, HLH, or Burkitt lymphoma/leukemia
Not Eligible

You will not qualify if you...

  • Aged 17 years or older (treated at UCL adolescent unit)
  • Have inflammatory bowel disease such as ulcerative colitis or Crohn's disease
  • Previously treated with chemotherapy at another institution

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Great Ormond Street Hospital

London, United Kingdom, WC1N 3JH

Actively Recruiting

Loading map...

Research Team

G

Graeme O'Connor, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here